Drug Type CRISPR/Cas |
Synonyms- |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization MyoPax GmbHStartup |
Active Organization MyoPax GmbHStartup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Muscular Dystrophies, Limb-Girdle | Preclinical | DE | MyoPax GmbHStartup | 10 Jan 2024 |